Prostate Cancer Clinical Trial

Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies

Summary

The AirSeal® System will allow for lower carbon dioxide (CO2) absorption rates than the standard Endopath System.

View Full Description

Full Description

The primary observation to be made is the level of carbon dioxide in the arterial blood, specifically when the patient is insufflated and deflated during the surgery. As a result of the consistent pressure that the AirSeal® system maintains, carbon dioxide will be absorbed in lower levels when compared to the standard of care systems in which fluctuations in intra-peritoneum pressure are seen.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age>18
Eligible and elect to undergo robotic prostatectomy surgery @ OhioHealth Dublin Methodist Hospital

Exclusion Criteria:

Age < 18
Emergency surgery
Ascites
BMI>44 or <18

Study is for people with:

Prostate Cancer

Estimated Enrollment:

109

Study ID:

NCT02114164

Recruitment Status:

Completed

Sponsor:

OhioHealth

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dublin Methodist Hospital
Columbus Ohio, 43016, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

109

Study ID:

NCT02114164

Recruitment Status:

Completed

Sponsor:


OhioHealth

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider